Stock Price
14.12
Daily Change
0.06 0.43%
Monthly
-3.42%
Yearly
27.09%
Q2 Forecast
14.12

Amarin reported $126.83M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
Amarin USD 126.83M 477K Dec/2025
AstraZeneca USD 17.88B 1.17B Mar/2026
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
DBV Technologies USD 15.97M 279K Sep/2025
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Halozyme Therapeutics USD 457.99M 16.72M Mar/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Ionis Pharmaceuticals USD 74M 8M Mar/2026
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Neurocrine Biosciences USD 768.1M 81.3M Mar/2026
Novartis USD 9.6B 2.69B Mar/2026